Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends
New

PTE
PolarityTE Inc
stock NASDAQ

At Close
5/20/2022 3:58:37 PM EDT
2.38USD-16.958%(-0.49)266,088
1.90Bid   2.88Ask   0.98Spread IEX
Pre-market
5/17/2022 9:26:24 AM EDT
3.24USD+13.287%(+0.38)0
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
237.514M
Headquarters
Salt Lake City, Utah, USA
Industry
Biotechnology
Next Earnings
2022-08-11 (81d)
Last Dividend
2016-01-190.336
Last Split
2022-05-171for25reverse
Jan 21, 2022
05:13AM EST  PolarityTE Receives Notice Of Allowance For US Patent Application 'Methods for Development & Use of Minimally Polarized Function Cell Micro-Aggregate Units in Tissue Applications Using LGR4, LGR5 & LGR6 Expressing Epithelial Stem Cell'   Benzinga
Jan 18, 2022
08:57AM EST  PolarityTE Inc. (PTE), a company focused on regenerative tissue products and biomaterials, said on Tuesday that it has received FDA clearance to commence the first of two planned phase III trials of SkinTE to treat chronic cutaneous ulcers.   RTTNews
08:08AM EST  PolarityTE Announces U.S. FDA Approval Of IND For Pivotal Phase 3 Study Of SkinTE To Support Chronic Cutaneous Ulcer Indication   Benzinga
08:02AM EST  PolarityTE : FDA Approves IND For Pivotal Phase 3 Study Of SkinTE To Support Chronic Cutaneous Ulcer Indication   RTTNews
08:02AM EST  PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of   PR Newswire
More News
Stats
Avg. Vol. 10 Day
663,787
Avg. Vol. 30 Day
302,092
Employees
59
Market Cap
237,514,176
Shares Out.
100,005,969
Float
72,178,958
P/E Ratio
-15.71
EPS (ttm)
-4.970
On/Off Exchange
50%/50%
6 Month Beta
1.04
1 Year Beta
0.91
2 Year Beta
0.78
3 Year Beta
0.89
52 Week Low
2.56
52 Week High
29.50
SMA50
5.03
SMA200
10.25
1 Week
-44.31%
1 Month
-54.26%
3 Month
-77.59%
6 Month
-80.61%
1 Year
-91.59%
2 Year
-89.33%
5 Year
-99.45%
Profile
PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates a dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.

PTE Stock Summary

PolarityTE Inc (NASDAQ:PTE) stock price today is $2.38, and today's volume is 266,088. PTE is down -16.958% today. The 30 day average volume is 302,092. PTE market cap is 237.514M with 100,005,969 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter @chartexchange_
© 2020 - 2022 ChartExchange LLC